Paradigm Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$1.05M 565
2024
Q3
$1.05M Hold
1,000
0.28% 158
2024
Q2
$1.05M Hold
1,000
0.29% 150
2024
Q1
$962K Hold
1,000
0.24% 179
2023
Q4
$878K Hold
1,000
0.23% 190
2023
Q3
$823K Hold
1,000
0.23% 189
2023
Q2
$719K Buy
1,000
+700
+233% +$503K 0.19% 207
2023
Q1
$247K Hold
300
0.07% 265
2022
Q4
$216K Sell
300
-1,000
-77% -$721K 0.06% 281
2022
Q3
$896K Hold
1,300
0.3% 104
2022
Q2
$768K Buy
1,300
+300
+30% +$177K 0.24% 164
2022
Q1
$698K Hold
1,000
0.18% 195
2021
Q4
$632K Hold
1,000
0.16% 221
2021
Q3
$605K Sell
1,000
-100
-9% -$60.5K 0.17% 227
2021
Q2
$614K Hold
1,100
0.16% 248
2021
Q1
$520K Hold
1,100
0.14% 260
2020
Q4
$531K Buy
1,100
+100
+10% +$48.3K 0.15% 248
2020
Q3
$560K Hold
1,000
0.17% 234
2020
Q2
$624K Buy
+1,000
New +$624K 0.19% 223
2019
Q2
Sell
-150
Closed -$61.6K 418
2019
Q1
$61.6K Sell
150
-50
-25% -$20.5K 0.02% 349
2018
Q4
$74.7K Sell
200
-100
-33% -$37.4K 0.02% 324
2018
Q3
$121K Hold
300
0.03% 313
2018
Q2
$103K Hold
300
0.03% 314
2018
Q1
$103K Hold
300
0.03% 315
2017
Q4
$113K Sell
300
-100
-25% -$37.6K 0.03% 311
2017
Q3
$179K Hold
400
0.05% 290
2017
Q2
$196K Hold
400
0.04% 347
2017
Q1
$155K Buy
+400
New +$155K 0.03% 426
2013
Q4
Sell
-780
Closed -$244K 838
2013
Q3
$244K Hold
780
0.04% 456
2013
Q2
$175K Buy
+780
New +$175K 0.03% 475